Latest News
Conference Coverage
Is MRI a viable alternative to lumbar puncture for MS diagnosis?
In many cases, the central vein sign on MRI could obviate the need for a spinal tap.
From the Journals
Patients with schizophrenia may be twice as likely to develop dementia
There is increasing evidence that multiple psychiatric symptoms and diagnoses are associated with cognitive decline and dementia.
Conference Coverage
NfL levels might presage MS disability
A spike occurred about a year before clinical worsening.
Feature
Younger doctors call for more attention to patients with disabilities
As the number of people with intellectual and developmental disabilities grows, medical educators look to the next generation of physicians to...
From the Journals
Concerning trend of growing subarachnoid hemorrhage rates in Black people
“Addressing this racial disparity will require multidisciplinary factors targeted not just at subarachnoid hemorrhage risk factors but also at...
Conference Coverage
A better way to predict fall risk in patients with MS?
“Instead of looking at reduced maximum muscle strength, perhaps we should start looking at reduced rate of force development when trying to...
Conference Coverage
‘Reassuring data’ for two MS meds in pregnancy
Preterm birth, spontaneous abortions, and major congenital anomalies were rare with anti-CD20 drugs ocrelizumab or natalizumab.
Literature Review
Viagra, Cialis, and Alzheimer’s risk: New data
“The evidence for the use of the drug was never sufficient for clinicians to use it in their patients.”
Conference Coverage
Should McDonald criteria include optical nerve lesions?
Researchers come out in favor, with a caveat against misdiagnoses.
Conference Coverage
Stem cell transplantation ‘substantially’ superior to fingolimod in cutting MS relapse risk
AHSCT is substantially superior to fingolimod and marginally superior to natalizumab in reducing the risk of posttreatment relapses.
Latest News
Has the pandemic affected babies’ brain development?
A large study finds that generally, brain development in infants ages 6-12 months old was not changed by the pandemic, but two areas raised...